Mcsnacks H Tupack
Excellent Contributor
commented on a stock · Jan 14, 2022 09:50
Looks right
$ChemoCentryx (CCXI.US)$ CHMP opinion was 11-12-21. EU marketing approval due before 1-18-22 Strong Buy recommendation on the stock. Raymond James has a Street high target of $110 per share for ChemoCentryx (CCXI) to imply a premium of ~240.0% to the last close. Also coming off a triple bottom bounce.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Mcsnacks H Tupack
OP
:
Tomorrow will be the last day to get in before announcement. A lot of shorts haven’t covered like last time. Last time it doubled the price.
Day Trader 881
:
Super strong support at 32.. but do remember what they did to us the day before FDA during AH….. stop loss hunted , which is manipulation at its best.. not setting stop loss this time round. Good luck everyone
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Mcsnacks H Tupack OP : Tomorrow will be the last day to get in before announcement. A lot of shorts haven’t covered like last time. Last time it doubled the price.
babyya : @Jzng@Jeanstarxin
silverelf : Moving from CNTX back to CCXI?
风光3265 silverelf : That's what I thought.
Day Trader 881 : Super strong support at 32.. but do remember what they did to us the day before FDA during AH….. stop loss hunted , which is manipulation at its best..
not setting stop loss this time round.
Good luck everyone
Invest and learn : Extracted text from website (https://www.ema.europa.eu/en/about-us/what-we-do/authorisation-medicines)
Cat army silverelf : Nope from CNTX.US to PETZ.US to CCXI.US

Mcsnacks H Tupack OP silverelf : This will be one of the few stocks that will finish in the green today. 3 day weekends are brutal for the market
babyya Mcsnacks H Tupack OP : When will think the ccxi will appoval date?
Bernard With Bacon babyya : Next Monday
View more comments...